Although telemedicine is not new to ophthalmology, the 2020 coronavirus pandemic has heightened the need for options that keep patients and eye care providers safe. Eye care providers need to be educated on the changing regulations related to office visits and billing, the enhanced safety measures required, and the ocular conditions best suited for telemedicine.
Supported by an unrestricted educational grant from Eyevance.
This initiative is designed to address and resolve the educational needs through the following educational objectives:
Provided by Evolve Medical Education
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jack Chapman, MD
Gainesville Eye Associates
Ranjan P. Malhotra, MD, FACS
St. Louis, MO
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Jack Chapman, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Eyevance and Sun Pharma. Speaker’s Bureau: Alcon, Johnson & Johnson Vision and Sun Pharma.
Ranjan P. Malhotra, MD, FACS, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Aimmax Therapeutics, Carl Zeiss Meditec, Hovione, Kala Pharmaceuticals, Insite Pharmaceuticals, Ocugen, Perrigo, Sight Sciences, and Silk Tech, Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Biotissue, EyePoint, Eyevance, Kala Pharmaceuticals, Novartis and Sun Pharma.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Eyevance.